← Open Payments lookup

ANN-MARIE COBB: Open Payments

NPI 1104927748 · LAPLATA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,694 in 71 payments from 24 companies in 2025. Trend: 2023 $2,384 · 2024 $5,060 · 2025 $3,694

Food & beverage: $1,869Travel & lodging: $1,757Education: $68
CompanyPaymentsAmount
Eli Lilly and Company3$1,212
Novartis Pharmaceuticals Corporation7$943
Bayer Healthcare Pharmaceuticals Inc.11$270
SCPHARMACEUTICALS INC.9$265
Novo Nordisk Inc7$142
Lilly USA, LLC6$137
AstraZeneca Pharmaceuticals LP3$85
Zimmer Biomet Holdings, Inc.1$77
OPKO Pharmaceuticals, LLC3$68
AKEBIA THERAPEUTICS INC2$54

Products named: Kerendia, FUROSCIX, Ozempic, MOUNJARO, ROSA, RAYALDEE, JARDIANCE, Vafseo.

Industry payments across MD — which companies pay providers there.